It was estimated that in 2025 around 313,780 men in the United States would develop prostate cancer. This statistic depicts the estimated number of new cancer cases among men in the U.S. in 2009 and 2025, by cancer type.

As of 2019, the risk of developing cancer among men over their lifetime in Germany progressively decreased with their age increasing. As a matter of fact, the highest risk of developing cancer through their remaining lifetime was reported by men aged 35 years, with 52.3 percent. This statistic depicts the men's risk of developing cancer in their lifetime in Germany as of 2019, by age.

In the period 2018-2019, 2021, it was estimated that U.S. men aged 65 to 84 years and older had a 10.6 percent chance of developing prostate cancer. This statistic shows the probability of males in the United States developing prostate cancer in 2018-2019, 2021, by age.

In the period from 2017 to 2021, the incidence rate for prostate cancer among Hispanic Americans was 88.1 per 100,000 population. This statistic shows the incidence rate of prostate cancer among U.S. males from 2017 to 2021, by race and ethnicity.

Cancer was responsible for around 142 deaths per 100,000 population in the United States in 2022. The death rate for cancer has steadily decreased since the 1990’s, but cancer still remains the second leading cause of death in the United States. The deadliest type of cancer for both men and women is cancer of the lung and bronchus which will account for an estimated 65,790 deaths among men alone in 2024. Probability of surviving Survival rates for cancer vary significantly depending on the type of cancer. The cancers with the highest rates of survival include cancers of the thyroid, prostate, and testis, with five-year survival rates as high as 99 percent for thyroid cancer. The cancers with the lowest five-year survival rates include cancers of the pancreas, liver, and esophagus. Risk factors It is difficult to determine why one person develops cancer while another does not, but certain risk factors have been shown to increase a person’s chance of developing cancer. For example, cigarette smoking has been proven to increase the risk of developing various cancers. In fact, around 81 percent of cancers of the lung, bronchus and trachea among adults aged 30 years and older can be attributed to cigarette smoking. A recent poll indicated that many U.S. adults believed smoking cigarettes and using other tobacco products increased a person’s risk of developing cancer, but a much smaller percentage believed the same for proven risk factors such as obesity and drinking alcohol.

As of 2019, the risk of developing cancer over the next decade among men in Germany progressively increased with age. The highest risk of developing cancer over the next ten years was reported by men aged 75 years, with 29.2 percent. This statistic depicts men's risk of developing cancer in the next ten years in Germany as of 2019, by age.

The risk of developing cancer under the age of 25 years in Sweden as of 2023 was 0.5 and 0.6 percent respectively for men and women. The risk was slightly higher among women than men, except for between 65 and 75 years, where the risk was higher among men. For men older than 65, but under the age of 75, the cumulative risk of developing cancer was 32.3 percent. For women in the same age group, the risk was 29.5 percent.

Prostate cancer was the most frequently diagnosed type of cancer in men in Russia, accounting for over 19 percent of total cases registered in 2023. Ranking second was trachea, bronchus, and lung cancer, having represented around 15 percent of cases in that year. In women, the leading type was breast cancer in Russia.

According to the data, the rate of liver cancer diagnoses among men in 2021 was around 12 per 100,000 population, while it was five per 100,000 population among women. This statistic depicts the rate of new U.S. liver cancer diagnoses in 2021, by gender.

The rate of liver cancer diagnoses in the United States increases with age. As of 2021, those aged 75 to 79 years had the highest rates of liver cancer. Risk factors for liver cancer include smoking, drinking alcohol, being overweight or obese, and having diabetes. Who is most likely to get liver cancer? Liver cancer in the United States is much more common among men than women. In 2021, there were 12.3 new liver cancer diagnoses among men per 100,000 population, compared to just five new diagnoses per 100,000 women. Concerning race and ethnicity, non-Hispanic American Indians and Alaska Natives and Hispanic have the highest rates of new liver cancer diagnoses. The five-year survival rate for liver cancer in the United States is around 22 percent, however, this rate is much higher among non-Hispanic Asian and Pacific Islanders than other races and ethnicities. Non-Hispanic Asian and Pacific Islanders have a 33 percent chance of surviving the next five years after a liver cancer diagnosis. Deaths from liver cancer In 2020, there were an estimated 20,262 deaths in the United States due to liver cancer. However, the death rate for liver cancer has decreased over the past few years. In the period 1999 to 2020, the death rate for liver cancer reached a high of five deaths per 100,000 population in 2015 but dropped to 4.6 deaths per 100,000 population by 2020. It is estimated that in 2024, there will be over 19,000 liver and intrahepatic bile duct cancer deaths among men in the United States and 10,700 such deaths among women.

The rate of skin cancer in the United States increased for both sexes from 1999 to 2021, with the rate for males consistently higher than that of females. This statistic shows the incidence rate of skin cancer in the U.S. from 1999 to 2021, by gender, per 100,000 population.

In the period 2018 to 2022, a total of approximately 173 men per 100,000 inhabitants died of cancers of all kinds in the United States, compared to an overall cancer death rate of 126 per 100,000 population among women. This statistic shows cancer death rates in the U.S. for the period from 2018 to 2022, by type and gender.

Most U.S. adults believed men got prostate cancer screenings because they show symptoms of having prostate cancer. However, early stage prostate cancer often does not show symptoms. More women believed this than men.

Every year numerous new cases of cancer are diagnosed in Italy. The figure presented refer to the share of specific tumors out of the total number of cancers diagnosed among males in 2020 and in 2022, when the data is available. According to the source, prostate cancer registered the highest incidence among males in 2022, with 19.8 percent, followed by lung tumor, with 15 percent.

The incidence of prostate cancer among men in Sweden fluctuated during the period from 2008 to 2023. The highest incidence rate was in 2009 and 2014, when the rate was 230 cases per hundred thousand inhabitants. In 2023, the rate was 214 cases per hundred thousand inhabitants.

In 2023, the number of prostate cancer cases among Japanese men was estimated to be highest, at around 98.6 thousand. Following were stomach cancer, estimated to reach around 90.7 thousand cases, and colon and rectum cancer with around 89 thousand cases that year.

In 2024, roughly 40,200 males were estimated to be newly diagnosed with prostate cancer in Italy. Pertaining to new diagnosis among males, prostate cancer was the one with the highest incidence, followed by lung and colorectal tumors, with almost 31,900 and 27,500 new cases, respectively.   Most frequently diagnosed cancers among females Breast cancer was the most common type of cancer among females. In fact, in 2024 breast cancer accounted for 53,065 new cancer cases diagnosed among women. Colorectal cancer followed with 21,233 new cases.   Cancer mortality rates and clinical trials The cancer mortality rate in Italy has generally decreased over time, even though the decline was more remarkable among men than women. In 2021, the cancer mortality rate was higher in the South and in the islands than in other Italian areas. In 2021, Sicily was the region with the highest prostate cancer mortality rate, while Sardinia was found to be the region with the most significant breast cancer mortality rate.  

The incidence rate of prostate cancer in Manitoba was estimated to be 119 cases per 100,000 population in males in 2023. This statistic displays the estimated incidence rate of the three most common cancers among males in Canada by province, as of 2023.

The number of lung cancer cases recorded in Italy significantly increased from 2010 to 2015, among both men and women. However, this disease was more common among males than females. The main risk factors increasing the chances of getting lung cancer are smoking and exposure to toxic substances, such as asbestos, radon and heavy metals.
  Lung cancer prevalence In 2020, lung tumor was one of the most frequently diagnosed cancer among both males and females. As a matter of fact, lung cancer accounted for 14.1 percent of the diagnoses among men. In the same year, it was estimated that 27,554 men and 13,328 women were newly diagnosed with lung cancer.
  Deaths caused by lung cancer In 2014, trachea, bronchus and lung cancers were among the main causes of death in Italy. The geographical distribution of deaths caused by these types of tumors in 2020, reveals that they were mainly prevalent among men living in the North-West of the country.

In 2022, there were an estimated 2.48 million new cases of trachea, bronchus, and lung cancer worldwide. Breast cancer was the second most common cancer type at that time with around 2.3 million new cases worldwide.

Number of new cancer cases

Cancer can be caused by internal factors like genetics and mutations, as well as external factors such as smoking and radiation. It occurs in the presence of uncontrolled growth and spread of abnormal cells. However, many cancer cases could be prevented, for example, by omitting cigarette usage and heavy alcohol consumption. Risk of developing cancer tends to increase with age and is most common in older adults. Nevertheless, cancer can develop in individuals of any age. Cancer can be treated through surgery, radiation, and chemotherapy, among other methods.

In the United States, there will be an estimated two million new cancer cases and 611,720 deaths in 2024. Among U.S. men, prostate cancer and lung and bronchus cancers are the most common cancer types as of 2024, totaling an estimated 299,010 and 116,310 cases, respectively. In women, breast cancer and lung and bronchus cancer are the most common newly diagnosed types, totaling 310,720 and 118,270 cases, respectively.